Cargando…
An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects
BACKGROUND: There is limited knowledge of the effectiveness and safety profile of cinacalcet in pediatric patients with secondary hyperparathyroidism (sHPT) treated with dialysis. METHODS: This was an open-label, single-dose study conducted on 12 pediatric subjects with chronic kidney disease treate...
Autores principales: | Padhi, Desmond, Langman, Craig B., Fathallah-Shaykh, Sahar, Warady, Bradley A., Salusky, Isidro B., Lee, Edward, Wang, Christine, Posvar, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422455/ https://www.ncbi.nlm.nih.gov/pubmed/22639045 http://dx.doi.org/10.1007/s00467-012-2186-9 |
Ejemplares similares
-
An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis
por: Sohn, Winnie Y., et al.
Publicado: (2018) -
Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis
por: Warady, Bradley A., et al.
Publicado: (2020) -
Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients
por: Gonzalez, Elsa, et al.
Publicado: (2010) -
Successful treatment of calcific uremic arteriolopathy in a pediatric dialysis patient
por: Amin, Nimisha, et al.
Publicado: (2010) -
Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism
por: Ruderman, Irene, et al.
Publicado: (2018)